Format
Sort by

Send to:

Choose Destination

Results: 5

Related Articles by Review for PubMed (Select 19406933)

1.

Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.

Papineni S, Chintharlapalli S, Abdelrahim M, Lee SO, Burghardt R, Abudayyeh A, Baker C, Herrera L, Safe S.

Carcinogenesis. 2009 Jul;30(7):1193-201. doi: 10.1093/carcin/bgp092. Epub 2009 Apr 30.

2.

Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy.

Sankpal UT, Maliakal P, Bose D, Kayaleh O, Buchholz D, Basha R.

Curr Med Chem. 2012;19(22):3779-86. Review.

PMID:
22725697
3.

Therapeutic applications of NSAIDS in cancer: special emphasis on tolfenamic acid.

Basha R, Baker CH, Sankpal UT, Ahmad S, Safe S, Abbruzzese JL, Abdelrahim M.

Front Biosci (Schol Ed). 2011 Jan 1;3:797-805. Review.

PMID:
21196413
4.

Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target.

Safe S, Imanirad P, Sreevalsan S, Nair V, Jutooru I.

Expert Opin Ther Targets. 2014 Jul;18(7):759-69. doi: 10.1517/14728222.2014.914173. Epub 2014 May 3. Review.

PMID:
24793594
5.

Sp1 transcription factor: A long-standing target in cancer chemotherapy.

VizcaĆ­no C, Mansilla S, Portugal J.

Pharmacol Ther. 2015 Aug;152:111-24. doi: 10.1016/j.pharmthera.2015.05.008. Epub 2015 May 8. Review.

PMID:
25960131
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk